131 related articles for article (PubMed ID: 26323904)
1. Tumor M2 pyruvate kinase in diagnosis of nonsmall cell lung cancer: A meta-analysis based on Chinese population.
Liu J; Zhu H; Jiang H; Zhang H; Wu D; Hu X; Zhang H
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C104-6. PubMed ID: 26323904
[TBL] [Abstract][Full Text] [Related]
2. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
3. Tumor M2-pyruvate kinase in stool as a biomarker for diagnosis of colorectal cancer: A meta-analysis.
Huang JX; Zhou Y; Wang CH; Yuan WW; Zhang ZD; Zhang XF
J Cancer Res Ther; 2014 Nov; 10 Suppl():C225-8. PubMed ID: 25450288
[TBL] [Abstract][Full Text] [Related]
4. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer.
Yan R; Chi L; Zheng X; Sun R; You J; Ye X
Indian J Cancer; 2015 Dec; 52 Suppl 2():e116-8. PubMed ID: 26728668
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of microRNA-25 in patients with non-small cell lung cancer in Chinese population: A systematic review and meta-analysis.
Li C; Sun L; Zhou H; Yang Y; Wang Y; She M; Chen J
Medicine (Baltimore); 2020 Dec; 99(51):e23425. PubMed ID: 33371070
[TBL] [Abstract][Full Text] [Related]
7. [The significance of TU M2-PK tumor marker for lung cancer diagnostics].
Oremek G; Kukshaĭte R; Sapoutzis N; Ziolkowski P
Klin Med (Mosk); 2007; 85(7):56-8. PubMed ID: 17882813
[TBL] [Abstract][Full Text] [Related]
8. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
9. Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.
Schneider J; Neu K; Grimm H; Velcovsky HG; Weisse G; Eigenbrodt E
Anticancer Res; 2002; 22(1A):311-8. PubMed ID: 12017309
[TBL] [Abstract][Full Text] [Related]
10. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.
Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S
J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of the diagnostic value of circulating microRNA-17-5p in patients with non-small cell lung cancer.
Hao J; Shen Z
Medicine (Baltimore); 2023 Feb; 102(8):e33070. PubMed ID: 36827064
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.
Zhang T; Liu W; Li L; Jue Z; Xu C
BMC Pulm Med; 2022 Aug; 22(1):307. PubMed ID: 35948914
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.
Wang H; Wu S; Zhao L; Zhao J; Liu J; Wang Z
Respirology; 2015 Jan; 20(1):56-65. PubMed ID: 25440223
[TBL] [Abstract][Full Text] [Related]
14. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
15. Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.
Schneider J; Morr H; Velcovsky HG; Weisse G; Eigenbrodt E
Cancer Detect Prev; 2000; 24(6):531-5. PubMed ID: 11198266
[TBL] [Abstract][Full Text] [Related]
16. Endostar combined with chemotherapy compared with chemotherapy alone in the treatment of nonsmall lung carcinoma: A meta-analysis based on Chinese patients.
Wang J; Gu LJ; Fu CX; Cao Z; Chen QY
Indian J Cancer; 2014 Mar; 51 Suppl 3():e106-9. PubMed ID: 25818734
[TBL] [Abstract][Full Text] [Related]
17. The Diagnostic Value of Pyruvate Kinase Isoenzyme Type M2 for Biliary Tract Carcinoma. A Systematic Review and Meta-Analysis.
Wang WQ; Liu W; Zhang N; Wang PH; Cao JZ; Chen JM; Li BL; He XD
J Gastrointestin Liver Dis; 2018 Mar; 27(1):73-81. PubMed ID: 29557418
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of CEA for lung cancer-related malignant pleural effusion in China: a meta-analysis.
Cheng C; Yang Y; Yang W; Wang D; Yao C
Expert Rev Respir Med; 2022 Jan; 16(1):99-108. PubMed ID: 34112035
[TBL] [Abstract][Full Text] [Related]
19. Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot study.
Schneider J; Neu K; Velcovsky HG; Morr H; Eigenbrodt E
Cancer Lett; 2003 Apr; 193(1):91-8. PubMed ID: 12691828
[TBL] [Abstract][Full Text] [Related]
20. Ventana immunohistochemistry assay for anaplastic lymphoma kinase gene rearrangement detection in patients with non-small cell lung cancer: A meta-analysis.
Zhiwei W; Yuan J; Yihui Y; Xin H; Jingtao C; Lei S; Yongjian D
Thorac Cancer; 2017 Sep; 8(5):471-476. PubMed ID: 28742247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
